Cha Kyong Yom

774 citations
23 papers · 583 indexed · h-index 15

Cha Kyong Yom

23 papers receiving 578 citations

Peers

Cha Kyong Yom
Comparison fields: 5 of 70
  • Cancer Research 220
  • Pathology and Forensic Medicine 166
  • Dermatology 65
  • Immunology and Allergy 34
  • Oncology 143
Replace Christina Finlayson with:
Christina Finlayson United States
Yurdanur Süllü Türkiye
A. Manzari Italy
J. F. R. Robertson United Kingdom
Sally Lane United Kingdom
M Gerstenhauer Germany
T. Megha Italy
Samanta Sarti Italy
Marko Buta Serbia
C I Li United States
Cha Kyong Yom relative to Christina Finlayson United States Christina Finlayson's profile →
Citations per field
00.5×4.9×
Christina Finlayson · 1×
Citations per year

Countries citing papers authored by Cha Kyong Yom

Since Specialization
Citations

This map shows the geographic impact of Cha Kyong Yom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cha Kyong Yom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cha Kyong Yom more than expected).

Fields of papers citing papers by Cha Kyong Yom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cha Kyong Yom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cha Kyong Yom. The network helps show where Cha Kyong Yom may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cha Kyong Yom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cha Kyong Yom Line = papers co-authored together Cha Kyong Yom links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20203
2 201564
3 201513
4 201424
5 201414
6 201423
7 201453
8 201320
9 20132
10 201237
11 201249
12 201211
13 201253
14 201156
15 201041
16 200933
17 200923
18 20095
19
Clusterin overexpression and relapse-free survival in breast cancer.
200928
20 20081

About Cha Kyong Yom

Cha Kyong Yom is a scholar working on Biological Psychiatry, Pathology and Forensic Medicine and Dermatology, having authored 23 papers that have together received 583 indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (5 papers), BRCA gene mutations in cancer (4 papers), Breast Cancer Treatment Studies (4 papers), Cancer and Skin Lesions (3 papers), Nutrition, Genetics, and Disease (3 papers), MRI in cancer diagnosis (2 papers), DNA Repair Mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (220 citations), Pathology and Forensic Medicine (166 citations) and Dermatology (65 citations). Cha Kyong Yom has collaborated with scholars based in South Korea, Ethiopia and Puerto Rico. Frequent co-authors include Hee Sung Kim, Wonshik Han, Dong‐Young Noh, So Yeon Park, Byung-In Moon, Sung‐Won Kim, Dong‐Young Noh, Dong-Won Kim, Eunyoung Kang and In Ae Park. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Annals of Surgical Oncology, Surgical Endoscopy and Familial Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026